Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
Naveen Vasudev(University of Leeds), Andrew R. Reynolds(Breast Cancer Now)
Cited by 732
Related Papers
ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A
|Nature Communications|2016|386
Variation in genomic landscape of clear cell renal cell carcinoma across Europe
|Nature Communications|2014|200